Items Tagged ‘antiplatelet’

March 17, 2021

Data show clear benefit from genetic testing before prescribing antiplatelet therapy

By Susan Murphy Susan Murphy (@susanmurphy)

By Terri Malloy Pharmacogenomics is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects. New research, funded in part by the National Heart, Lung and Blood Institute (NHLBI), shows  a clear advantage of genetic testing in helping health care providers […]

View full entry

Tags: antiplatelet, antiplatelet medication, coronary heart disease, Genetic Testing, pharmacogenomics

February 6, 2014

Your Genotype and Your Heart Health

By Center for Individualized Medicine Center for Individualized Medicine (@samuelsmith5209)

Each year in the United States, 600,000 to 800,000 heart stents are placed to restore blood flow through coronary arteries. Patients are then given medication to keep blood clots from forming near the surgical site. Such clots can be deadly, causing heart attack and stroke. But, which antiplatelet medication is best? The answer may lie in your genes. “The […]

View full entry

Tags: antiplatelet, antiplatelet medication, clopidogrel, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics, heart, heart attack, Heart Health

November 14, 2013

Genomics Of Antiplatelet Heart Medication Study At Mayo Clinic

By AJ Montpetit AJ Montpetit (@ajmontpetit)

Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States. The answer may lie in your genes, but professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s recent recommendation that patients undergo genetic testing before taking Plavix (clopidogrel bisulfate). The […]

View full entry

Tags: antiplatelet, Cardiovascular Disease, center for individualized medicine, Genetic Testing, genome, genomics, heart medication, individualized medicine, mayo clinic, Naveen Pereira, personalized care, Personalized Medication

August 20, 2013

Genomics May Settle Debate on Best Antiplatelet Medication After Stenting

By AJ Montpetit AJ Montpetit (@ajmontpetit)

600,000 angioplasties are performed every year in the United States, which has raised the question of which antiplatelet medication is best after a coronary stent. Looking to individual’s genome is where the Center for Individualized Medicine is studying, with their newly launched TAILOR-PCI study. This study examines the CYP2C19 genotype of a patient to determine […]

View full entry

Tags: angioplasty, antiplatelet, antiplatelet medication, center for individualized medicine, individualized medicine, mayo clinic, personalized medicine, pharmacogenomics

Contact Us · Privacy Policy